Britt Van Renterghem
3PUBLICATIONS
9CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (3)
Sort by Publication Date:
|Jul 27, 2022
Enapotamab Vedotin, an AXL-Specific Antibody-Drug Conjugate, Demonstrates Antitumor Efficacy in Patient-Derived Xenograft Models of Soft Tissue Sarcoma.Britt Van Renterghem, Agnieszka Wozniak, Patricia Garrido Castro
|Apr 23, 2022
Enhanced Antitumor Efficacy of PhAc-ALGP-Dox, an Enzyme-Activated Doxorubicin Prodrug, in a Panel of THOP1-Expressing Patient-Derived Xenografts of Soft Tissue Sarcoma.Britt Van Renterghem, Agnieszka Wozniak, Ludovica Tarantola
|Feb 12, 2022
PhAc-ALGP-Dox, a Novel Anticancer Prodrug with Targeted Activation and Improved Therapeutic Index.Andrea Casazza, Lawrence Van Helleputte, Britt Van Renterghem
Pageof 1
Frequent Collaborators
3 joint publications
Patrick Schöffski
2 joint publications
Andrea Casazza
2 joint publications
Agnieszka Wozniak
1 joint publications
Lawrence Van Helleputte
1 joint publications
Peter Pokreisz
1 joint publications
Carla Riera-Domingo
1 joint publications
Olivier Defert
1 joint publications
Ludovica Tarantola
1 joint publications
Che-Jui Lee
